Visceral leishmaniasis, which is also known as Kala-Azar, is one of the most severely
neglected tropical diseases recognized by the World Health Organization (WHO). The threat …

Toxoplasmosis is a cosmopolitan zoonotic infection, caused by a unicellular protozoan
parasite known as Toxoplasma gondii that belongs to the phylum Apicomplexa. It is …

Background Visceral leishmaniasis (VL) caused by dimorphic Leishmania species is a
parasitic disease with high socioeconomic burden in endemic areas worldwide. Sustaining …

Background The therapy of visceral leishmaniasis (VL) is limited by resistance, toxicity and
decreased bioavailability of the existing drugs coupled with dramatic increase in HIV-co …

Background In the absence of vaccines and limitations of currently available chemotherapy,
development of safe and efficacious drugs is urgently needed for visceral leishmaniasis (VL) …

Toxoplasmosis is a cosmopolitan zoonotic disease, which infect several warm-blooded
mammals. More than one-third of the human population are seropositive worldwide. Due to …

The development of prophylactic vaccines is important in preventing and controlling
diseases such as visceral leishmaniasis (VL), in addition to being an economic measure for …

Background: Hypervariability of HCV proteins is an important obstacle to design an efficient
vaccine for HCV infection. Multi-epitope vaccines containing conserved epitopes of the virus …

Giardia lamblia (G. lamblia) is an important cause of severe malabsorption, weight loss,
physical and mental retardation especially in infants and children throughout the world …

Background Vaccine development has been a priority in the fight against leishmaniases,
which are vector-borne diseases caused by Leishmania protozoa. Among the different …